Disorder of the intestinal microbial tissue complex after a new coronavirus infection as an interdisciplinary problem
Russian Family Doctor · 2022
DOI: 10.17816/rfd101087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Family Doctor, 2022. Verfasst von Marina S. Grigorovich. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The occurrence of diarrhea in comorbid patients with COVID-19 infection against the background of microbiocenosis disorders may be a factor in the worse outcome of the disease. The biggest threat posed by diarrhea is dehydration. Evaluation, control and timely correction of disorders of the gastrointestinal tract, allowing to identify signs associated with dehydration, impaired water and electrolyte balance, intestinal microecology and phenomena of increased epithelial permeability. It is important to consider the risk of diarrhea in patients undergoing massive therapy for COVID-19. On the example of a specific clinical case, the most common mistakes in managing patients with acute/persistent diarrhea are analyzed. The tactics of managing a patient with diarrheal syndrome after a COVID-19 infection has been defined and substantiated, the importance of a holistic approach to solving patient problems from the standpoint of the one health concept has been substantiated.
Zitieren
APA
Grigorovich, M. S. (2022). Disorder of the intestinal microbial tissue complex after a new coronavirus infection as an interdisciplinary problem. Russian Family Doctor. https://doi.org/10.17816/rfd101087
Vancouver
Grigorovich MS. Disorder of the intestinal microbial tissue complex after a new coronavirus infection as an interdisciplinary problem. Russian Family Doctor. 2022. doi:10.17816/rfd101087
BibTeX
@article{Grigorovich2022,
author = {Grigorovich, Marina S.},
title = {Disorder of the intestinal microbial tissue complex after a new coronavirus infection as an interdisciplinary problem},
journal = {Russian Family Doctor},
year = {2022},
doi = {10.17816/rfd101087}
}
EUVIMED